Recent advances in Helicobacter pylori eradication

被引：0
作者：
Niv, Yaron [1 ]
Rokkas, Theodore [2 ]
机构：
[1] Tel Aviv Univ, Rabin Med Ctr, Dept Gastroenterol, IL-69978 Tel Aviv, Israel
[2] Henry Dunant Hosp, Dept Gastroenterol, Athens, Greece
来源：
ANNALS OF GASTROENTEROLOGY | 2015年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：415 / +
页数：2
相关论文
共 14 条
  • [1] High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy for Helicobacter pylori Infections
    Attumi, Taraq A.
    Graham, David Y.
    [J]. HELICOBACTER, 2014, 19 (04) : 319 - 322
  • [2] Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence
    Graham, David Y.
    Lee, Yi-Chia
    Wu, Ming-Shiang
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (02) : 177 - +
  • [3] Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days
    Hsu, Ping-I.
    Wu, Deng-Chyang
    Wu, Jeng-Yih
    Graham, David Y.
    [J]. HELICOBACTER, 2011, 16 (02) : 139 - 145
  • [4] Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report
    Malfertheiner, Peter
    Megraud, Francis
    O'Morain, Colm A.
    Atherton, John
    Axon, Anthony T. R.
    Bazzoli, Franco
    Gensini, Gian Franco
    Gisbert, Javier P.
    Graham, David Y.
    Rokkas, Theodore
    El-Omar, Emad M.
    Kuipers, Ernst J.
    [J]. GUT, 2012, 61 (05) : 646 - 664
  • [5] Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
    McNicholl, A. G.
    Linares, P. M.
    Nyssen, O. P.
    Calvet, X.
    Gisbert, J. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 414 - 425
  • [6] Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment
    Szajewska, H.
    Horvath, A.
    Piwowarczyk, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (09) : 1069 - 1079
  • [7] Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials
    Tang, Hui-Lin
    Li, Yan
    Hu, Yong-Fang
    Xie, Hong-Guang
    Zhai, Suo-Di
    [J]. PLOS ONE, 2013, 8 (04):
  • [8] Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy
    Wang, Zhen-Hua
    Gao, Qin-Yan
    Fang, Jing-Yuan
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (01) : 25 - 32
  • [9] Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis
    Xiao, Shu-Ping
    Gu, Min
    Zhang, Guo-Xin
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (05) : 528 - 538
  • [10] Detection of Clarithromycin-Resistant Helicobacter pylori by Stool PCR in Children: A Comprehensive Review of Literature
    Xiong, Li Jing
    Tong, Yu
    Wang, Zhiling
    Mao, Meng
    [J]. HELICOBACTER, 2013, 18 (02) : 89 - 101
12